Bridged diazepan orexin receptor antagonists

Details for Australian Patent Application No. 2007272854 (hide)

Owner Merck & Co., Inc.

Inventors McGaughey, Georgia B.; Schreier, John D.; Coleman, Paul J.; Roecker, Anthony J.; Cox, Christopher D.

Agent Spruson & Ferguson

Pub. Number AU-A-2007272854

PCT Pub. Number WO2008/008517

Priority 60/831,178 14.07.06 US

Filing date 13 July 2007

Wipo publication date 17 January 2008

International Classifications

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

C07D 471/08 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

15 January 2009 PCT application entered the National Phase

  PCT publication WO2008/008517 Priority application(s): WO2008/008517

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007272855-Substituted diazepan orexin receptor antagonists

2007272839-4-amino-4-oxobutanoyl peptides as inhibitors of viral replication